ArticleAnnals of hematology2021

Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients.

Andrius Zucenka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.